Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 30, 2024
Data Byte
Nine PDUFA dates on FDA’s agenda in September
Decision on Zevra’s arimoclomol follows positive AdCom vote
BioCentury | Jan 24, 2024
Data Byte
Schizophrenia pipeline: two PDUFA dates and a dozen readouts in 2024
A look ahead to the schizophrenia milestones coming this year, and the mechanisms behind them
BioCentury | Apr 25, 2022
Data Byte
Mechanistic diversity in the pipeline for fragile X syndrome
The fragile X pipeline comprises as many drugs targets as drug candidates
BioCentury | Mar 4, 2022
Distillery Therapeutics
Targeting GABA signals for cancer checkpoint inhibitor resistance
BioCentury | Aug 13, 2021
Product Development
Aug. 12 Quick Takes: another hold for Aprea’s eprenetapopt
Plus Vyne, AlzeCure and Jazz
BioCentury | Oct 9, 2020
Deals
Oct. 8 Quick Takes: Kronos ready for NASDAQ debut; plus Sensei, TCRyption, Jazz, Pfizer-Opko and Moderna
Kronos raises $250M in NASDAQ IPOLook for shares of Kronos Bio Inc. (NASDAQ:KRON) to begin trading on Friday after the company raised $250 million in an IPO. The listing completes a busy few months
BioCentury | Sep 25, 2020
Emerging Company Profile
XWPharma: timing therapy to biological rhythm
XWPharma to use $40M series C to advance two lead neurology programs
BioCentury | Jul 24, 2020
Product Development
July 23 Quick Takes: Priority Review for Aurinia; plus Jazz, CymaBay, Biogen, Vertex, Grünenthal, Mesoblast, BMS and Genfit
BioCentury | Mar 27, 2020
Product Development
March 26 Quick Takes: Pear’s digital therapeutic approved for insomnia; plus Medimetriks-Otsuka, Merck KGaA, Jazz, Roche, EpiVax
Items per page:
1 - 10 of 103